- Home
- ARAY vs VYGR Comparison
ARAY vs VYGR Comparison
Compare ARAY & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- VYGR
- Stock Information
- Founded
- ARAY 1990
- VYGR 2013
- Country
- ARAY United States
- VYGR United States
- Employees
- ARAY N/A
- VYGR N/A
- Industry
- ARAY Medical/Dental Instruments
- VYGR Biotechnology: Pharmaceutical Preparations
- Sector
- ARAY Health Care
- VYGR Health Care
- Exchange
- ARAY Nasdaq
- VYGR Nasdaq
- Market Cap
- ARAY 229.3M
- VYGR 235.4M
- IPO Year
- ARAY 2007
- VYGR 2015
- Fundamental
- Price
- ARAY $2.11
- VYGR $4.22
- Analyst Decision
- ARAY Strong Buy
- VYGR Strong Buy
- Analyst Count
- ARAY 1
- VYGR 9
- Target Price
- ARAY $9.00
- VYGR $15.53
- AVG Volume (30 Days)
- ARAY 883.1K
- VYGR 380.0K
- Earning Date
- ARAY 02-05-2025
- VYGR 03-03-2025
- Dividend Yield
- ARAY N/A
- VYGR N/A
- EPS Growth
- ARAY N/A
- VYGR N/A
- EPS
- ARAY N/A
- VYGR 0.47
- Revenue
- ARAY $453,140,000.00
- VYGR $163,784,000.00
- Revenue This Year
- ARAY $6.97
- VYGR N/A
- Revenue Next Year
- ARAY $5.02
- VYGR N/A
- P/E Ratio
- ARAY N/A
- VYGR $9.05
- Revenue Growth
- ARAY 1.26
- VYGR 3.40
- 52 Week Low
- ARAY $1.40
- VYGR $4.00
- 52 Week High
- ARAY $2.95
- VYGR $10.66
- Technical
- Relative Strength Index (RSI)
- ARAY 43.05
- VYGR 29.98
- Support Level
- ARAY $2.15
- VYGR $4.20
- Resistance Level
- ARAY $2.32
- VYGR $4.60
- Average True Range (ATR)
- ARAY 0.16
- VYGR 0.31
- MACD
- ARAY -0.04
- VYGR -0.08
- Stochastic Oscillator
- ARAY 4.55
- VYGR 12.36
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.